This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Revaccination of pneumococcal vaccine

Authoring team

PCV13 and PCV15

  • a single priming dose of 0.5ml of PCV13 or PCV15 at 12 weeks of age
  • a booster dose of 0.5ml of PCV13 or PCV15 at one year of age (on or after their first birthday) given at the same time as the Hib/MenC, 4CMenB and MMR vaccines

PPV23

  • antibody levels are likely to decline rapidly in individuals with no spleen, splenic dysfunction or chronic renal disease - therefore re-immunisation with PPV23 is recommended every five years in these groups
  • revaccination is well tolerated
  • testing antibody levels prior to vaccination is not required
  • revaccination with PPV23 is currently not recommended for any other clinical risk groups or age groups.

Reference

  1. The Green Book. Chapter 25 - Pneumococcal (May 2025)

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.